• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“不是我是否会患癌症,而是我何时会患癌症”:BRCA基因呈阳性的患者关于遗传性乳腺癌和卵巢癌风险的(不)确定健康经历。

"It's not if I get cancer, it's when I get cancer": BRCA-positive patients' (un)certain health experiences regarding hereditary breast and ovarian cancer risk.

作者信息

Dean Marleah

机构信息

Department of Communication, University of South Florida, 4202 E. Fowler CIS 3057, Tampa, FL 33620, USA.

出版信息

Soc Sci Med. 2016 Aug;163:21-7. doi: 10.1016/j.socscimed.2016.06.039. Epub 2016 Jun 23.

DOI:10.1016/j.socscimed.2016.06.039
PMID:27376595
Abstract

RATIONALE

Women with a harmful mutation in the BReast CAncer (BRCA) gene are at significantly increased risk of developing hereditary breast and ovarian cancer (HBOC) during their lifetime, compared to those without. Such patients-with a genetic predisposition to develop cancer but who have not yet been diagnosed with cancer-live in a constant state of uncertainty and wonder not if they might get cancer but when.

OBJECTIVE

Framed by uncertainty management theory, the purpose of this study was to explore BRCA-positive patients' health experiences after testing positive for the BRCA genetic mutation, specifically identifying their sources of uncertainty.

METHODS

Thirty-four, qualitative interviews were conducted with female patients. Participants responded to online research postings on the non-profit organization Facing Our Risk of Cancer Empowered's (FORCE) message board and social media pages as well as HBOC-specific Facebook groups. The interview data were coded using the constant comparison method.

RESULTS

Two major themes representing BRCA-positive patients' sources of uncertainty regarding their genetic predisposition and health experiences emerged from the data. Medical uncertainty included the following three subthemes: the unknown future, medical appointments, and personal cancer scares. Familial uncertainty encompassed the subthemes traumatic family cancer memories and motherhood.

CONCLUSIONS

Overall, the study supports and extends existing research on uncertainty-revealing uncertainty is inherent in BRCA-positive patients' health experiences-and offers new insight regarding uncertainty management and HBOC risk.

摘要

理论依据

与未携带乳腺癌(BRCA)基因有害突变的女性相比,携带该突变的女性一生中患遗传性乳腺癌和卵巢癌(HBOC)的风险显著增加。这类具有患癌遗传易感性但尚未被诊断出癌症的患者,一直生活在不确定性之中,她们不是疑惑自己是否会患癌,而是何时会患癌。

目的

以不确定性管理理论为框架,本研究旨在探讨BRCA基因检测呈阳性的患者在检测后对自身健康的体验,特别是确定她们不确定性的来源。

方法

对34名女性患者进行了定性访谈。参与者回应了非营利组织“直面癌症风险”(FORCE)留言板、社交媒体页面以及特定的HBOC相关脸书群组上发布的在线研究招募信息。访谈数据采用持续比较法进行编码。

结果

数据中出现了两个主要主题,代表了BRCA基因检测呈阳性的患者在遗传易感性和健康体验方面不确定性的来源。医学不确定性包括以下三个子主题:未知的未来、医疗预约以及个人癌症恐慌。家庭不确定性包括创伤性家庭癌症记忆和为人母这两个子主题。

结论

总体而言,该研究支持并扩展了现有关于不确定性的研究——揭示了不确定性是BRCA基因检测呈阳性的患者健康体验中固有的——并为不确定性管理和HBOC风险提供了新的见解。

相似文献

1
"It's not if I get cancer, it's when I get cancer": BRCA-positive patients' (un)certain health experiences regarding hereditary breast and ovarian cancer risk.“不是我是否会患癌症,而是我何时会患癌症”:BRCA基因呈阳性的患者关于遗传性乳腺癌和卵巢癌风险的(不)确定健康经历。
Soc Sci Med. 2016 Aug;163:21-7. doi: 10.1016/j.socscimed.2016.06.039. Epub 2016 Jun 23.
2
Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer.遗传性乳腺癌和卵巢癌患者的不确定性管理策略。
Health Commun. 2018 Feb;33(2):122-130. doi: 10.1080/10410236.2016.1250187. Epub 2016 Dec 15.
3
Maximising survival: the main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2.最大限度提高生存率:进行 BRCA1/2 基因检测的遗传性乳腺癌和卵巢癌女性的主要关注点。
Eur J Oncol Nurs. 2014 Aug;18(4):411-8. doi: 10.1016/j.ejon.2014.03.007. Epub 2014 Apr 13.
4
"It was an Emotional Baby": Previvors' Family Planning Decision-Making Styles about Hereditary Breast and Ovarian Cancer Risk.“这是个情绪化的宝贝”:癌症遗传携带者家庭对遗传性乳腺癌和卵巢癌风险的计划生育决策方式
J Genet Couns. 2017 Dec;26(6):1301-1313. doi: 10.1007/s10897-017-0069-8. Epub 2017 Jan 30.
5
BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.来自遗传性乳腺癌和卵巢癌家族的BRCA突变阴性女性:对BRCA阴性经历的定性研究
Health Expect. 2008 Sep;11(3):220-31. doi: 10.1111/j.1369-7625.2008.00494.x.
6
Conditions and consequences of a BRCA mutation in young, single women of childbearing age.年轻育龄单身女性中BRCA基因突变的情况及后果。
Oncol Nurs Forum. 2010 Sep;37(5):627-34. doi: 10.1188/10.ONF.627-634.
7
Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.进行遗传性乳腺癌和卵巢癌基因检测的女性与其未进行检测的高危亲属之间的差异。
Oncol Nurs Forum. 2011 Sep;38(5):572-81. doi: 10.1188/11.ONF.572-581.
8
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.女性 BRCA 相关癌症的风险评估、遗传咨询和基因检测:美国预防服务工作组推荐声明。
Ann Intern Med. 2014 Feb 18;160(4):271-81. doi: 10.7326/M13-2747.
9
"When information is not enough": A model for understanding BRCA-positive previvors' information needs regarding hereditary breast and ovarian cancer risk.“信息不足”:理解 BRCA 阳性预存者对遗传性乳腺癌和卵巢癌风险相关信息需求的模型。
Patient Educ Couns. 2017 Sep;100(9):1738-1743. doi: 10.1016/j.pec.2017.03.013. Epub 2017 Mar 10.
10
Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.胚胎植入前基因诊断和产前诊断的决策:对遗传性乳腺癌和卵巢癌夫妇的一项挑战。
Hum Reprod. 2014 May;29(5):1103-12. doi: 10.1093/humrep/deu034. Epub 2014 Mar 6.

引用本文的文献

1
Exploring the role of germline genetic testing in surgical decision making for early-stage invasive breast cancer: insights from a safety-net hospital.探索生殖系基因检测在早期浸润性乳腺癌手术决策中的作用:来自一家安全网医院的见解。
J Community Genet. 2025 Jun 30. doi: 10.1007/s12687-025-00806-2.
2
Exploring the Emotional Effects of Reproductive Decision-Making in Women With a BRCA Pathogenic Variant.探索携带BRCA致病变异的女性生殖决策的情感影响。
Oncol Nurs Forum. 2025 Jun 12;52(4):302-312. doi: 10.1188/25.ONF.302-312.
3
Acceptability of the ePOWER intervention: Managing previvors' cancer-related uncertainty and supporting decision making.
ePOWER干预措施的可接受性:管理癌症高危人群与癌症相关的不确定性并支持决策制定。
PEC Innov. 2025 May 10;6:100402. doi: 10.1016/j.pecinn.2025.100402. eCollection 2025 Jun.
4
Beyond BRCA: A scoping review of person-centred care for women diagnosed with a BRCA gene mutation.超越BRCA:对诊断为BRCA基因突变的女性以患者为中心的护理的范围综述
BMJ Open. 2025 Mar 6;15(3):e094416. doi: 10.1136/bmjopen-2024-094416.
5
Need for specially designed educational support groups: Young women's experiences of being identified with BRCA pathogenic variants.对专门设计的教育支持小组的需求:年轻女性被鉴定携带BRCA致病变异体的经历
J Genet Couns. 2025 Apr;34(2):e1980. doi: 10.1002/jgc4.1980. Epub 2024 Sep 28.
6
Health-related quality of life and fear of progression in individuals with Li-Fraumeni syndrome.李-弗劳梅尼综合征患者的健康相关生活质量及疾病进展恐惧
J Genet Couns. 2025 Feb;34(1):e1859. doi: 10.1002/jgc4.1859. Epub 2024 Feb 13.
7
Understanding parents uncertainty sources and management strategies while caring for a child diagnosed with a hematologic cancer.了解父母在照顾被诊断患有血液系统癌症的孩子时的不确定性来源及管理策略。
PEC Innov. 2023 Aug 9;3:100198. doi: 10.1016/j.pecinn.2023.100198. eCollection 2023 Dec 15.
8
"Where do I go? Who do I go to?": BRCA Previvors, genetic counselors and family planning.“我该何去何从?我该求助于谁?”:BRCA基因携带者、遗传咨询师与计划生育
PEC Innov. 2023 Apr 23;2:100157. doi: 10.1016/j.pecinn.2023.100157. eCollection 2023 Dec.
9
Assessing Psychological Morbidity in Cancer-Unaffected Pathogenic Variant Carriers: A Systematic Review.评估癌症未受影响的致病性变异携带者的心理病态:系统评价。
Curr Oncol. 2023 Mar 25;30(4):3590-3608. doi: 10.3390/curroncol30040274.
10
Coping Self-Efficacy and Its Relationship with Psychological Morbidity after Genetic Test Result Disclosure: Results from Cancer-Unaffected Mutation Carriers.应对自我效能及其与遗传检测结果披露后心理病态的关系:癌症未受影响突变携带者的结果。
Int J Environ Res Public Health. 2023 Jan 17;20(3):1684. doi: 10.3390/ijerph20031684.